BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zintgraff J, Gagetti P, Napoli D, Sanchez Eluchans N, Irazu L, Moscoloni M, Regueira M, Lara CS, Corso A; Argentina Spn Working Group. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine 2021:S0264-410X(21)01616-9. [PMID: 34920903 DOI: 10.1016/j.vaccine.2021.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ryman J, Weaver J, Yee KL, Sachs JR. Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children. Expert Rev Vaccines 2022;:1-7. [PMID: 35997125 DOI: 10.1080/14760584.2022.2112179] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li Y, Guo Y, Duan Y. Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China. J Infect 2022:S0163-4453(22)00348-6. [PMID: 35659542 DOI: 10.1016/j.jinf.2022.05.040] [Reference Citation Analysis]